TipRanks
Advertisement
Advertisement
Ulta Beauty, Etsy upgraded: Wall Street’s top analyst calls
PremiumThe FlyUlta Beauty, Etsy upgraded: Wall Street’s top analyst calls
21d ago
Ascendis Pharma Unveils $400 Million Share Repurchase Program
Premium
Company Announcements
Ascendis Pharma Unveils $400 Million Share Repurchase Program
21d ago
Ascendis Pharma Regains Full Rights to TransCon Metabolic and Cardiovascular Programs After Novo Nordisk Split
Premium
Company Announcements
Ascendis Pharma Regains Full Rights to TransCon Metabolic and Cardiovascular Programs After Novo Nordisk Split
21d ago
Ascendis Pharma Posts Positive 52-Week Infant Achondroplasia Data for TransCon CNP
PremiumCompany AnnouncementsAscendis Pharma Posts Positive 52-Week Infant Achondroplasia Data for TransCon CNP
27d ago
Ascendis Pharma Grants New Employee Warrants and Updates Capital Structure in September 2026
Premium
Company Announcements
Ascendis Pharma Grants New Employee Warrants and Updates Capital Structure in September 2026
27d ago
Ascendis Pharma announces data from reACHin Trial
Premium
The Fly
Ascendis Pharma announces data from reACHin Trial
27d ago
BioMarin price target raised to $90 from $88 at Piper Sandler
PremiumThe FlyBioMarin price target raised to $90 from $88 at Piper Sandler
1M ago
Ascendis Pharma Strikes Global Settlement and Licensing Deal With BioMarin Over YUVIWEL
Premium
Company Announcements
Ascendis Pharma Strikes Global Settlement and Licensing Deal With BioMarin Over YUVIWEL
1M ago
H.C. Wainwright trims Ascendis target, says litigation overhang removed
Premium
The Fly
H.C. Wainwright trims Ascendis target, says litigation overhang removed
1M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―